GAD Clinical Trials

1 recruiting

GAD Trials at a Glance

34 actively recruiting trials for gad are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in São Paulo, Houston, and Dallas. Lead sponsors running gad studies include Karolinska Institutet, Tongji Hospital, and Assistance Publique Hopitaux De Marseille.

Treatments under study

About GAD Clinical Trials

Looking for clinical trials for GAD? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new GAD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about GAD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 34 trials

Recruiting
Not Applicable

Text Message Safety Behavior Fading for Pathological Worry

WorryingAnxietyGeneralized Anxiety Disorder (GAD)
Florida State University300 enrolled1 locationNCT07391020
Recruiting
Phase 4

Gadopiclenol vs. Gadobutrol for Dynamic Contrast-Enhanced Pituitary MRI (Magnetic Resonance Imaging)

Contrast Enhanced Images vs. Non-contrast ImagesGadopiclinol Enhanced Images vs. Gadobutrol Enhanced Images
UConn Health10 enrolled1 locationNCT06846853
Recruiting
Phase 3

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Hoffmann-La Roche152 enrolled82 locationsNCT05271409
Recruiting
Phase 1

Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.

Neuromyelitis Optica Spectrum Disorder (NMOSD)Multiple Sclerosis (MS)Myasthenia Gravis (MG)+3 more
Tongji Hospital6 enrolled1 locationNCT07526493
Recruiting
Not Applicable

Transdiagnostic Metacognitive Therapy Compared to Disorder-Specific Cognitive-Behavioral Therapy for Anxiety Disorders

Posttraumatic Stress Disorder (PTSD)Generalized Anxiety Disorder (GAD)Social Anxiety Disorder (SAD)
Karolinska Institutet86 enrolled1 locationNCT06937892
Recruiting

LHC-CIDI-5 in Hong Kong

Suicidal IdeationMajor Depressive Disorder (MDD)Bipolar I Disorder+14 more
The University of Hong Kong2,500 enrolled1 locationNCT06804525
Recruiting
Phase 3

Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder

Anxiety DisordersGeneralized Anxiety Disorder (GAD)
Wayne State University90 enrolled1 locationNCT07123467
Recruiting

A Novel Blood Test as a Biomarker in Mental Health

Depression - Major Depressive DisorderSubstance Use DisordersAlcohol Use Disorder+5 more
Fraser Health500 enrolled1 locationNCT06856161
Recruiting
Not Applicable

Stepped Care Treatment for Anxiety Resilience

Obsessive Compulsive Disorder (OCD)Specific PhobiaGeneralized Anxiety Disorder (GAD)+3 more
Andrew Wiese106 enrolled1 locationNCT07228143
Recruiting
Not Applicable

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

Chronic InsomniaGeneralized Anxiety Disorder (GAD)
University of Sao Paulo30 enrolled1 locationNCT07429578
Recruiting
Phase 2

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD)
AbbVie315 enrolled52 locationsNCT06846320
Recruiting

National Network for Cardiovascular Genomics: Advancing Cardiovascular Healthcare for Hereditary Diseases in Brazil's Unified Health System Through a Multicenter Registry

Sudden Cardiac DeathArrhythmogenic Right Ventricular DysplasiaCardiomyopathy, Dilated+11 more
Hospital do Coracao600 enrolled27 locationsNCT06546137
Recruiting
Not Applicable

Intracranial Neurophysiological Signatures of Fear and Anxiety in Humans

FearPTSDGAD+1 more
Duke University80 enrolled2 locationsNCT05120635
Recruiting

Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups

Depression - Major Depressive DisorderAnorexia NervosaBulimia Nervosa+17 more
Forschungsinstitut der Diabetes Akademie Mergentheim1,809 enrolled3 locationsNCT07212075
Recruiting

Long-term Result of DTPA (Diethylenetriamine Pentaacetate) Chelation for Gadolinium Deposition Disease

Gadolinium Deposition DiseaseCa-DTPA
Stanford University50 enrolled1 locationNCT06269055
Recruiting

Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging

Multiple SclerosisAlzheimer DiseaseParkinson Disease+2 more
Assistance Publique Hopitaux De Marseille700 enrolled1 locationNCT07202494
Recruiting
Not Applicable

The Effect of Patient Preference for Treatment Model in Internet Delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD)
Karolinska Institutet440 enrolled1 locationNCT07201844
Recruiting

Medium-term Effects of Treatments in Autoimmune Encephalitis

GFAPNMDAR Autoimmune EncephalitisLGI1 Antibody Associated Encephalitis+3 more
Hospices Civils de Lyon200 enrolled1 locationNCT07133113
Recruiting
Not Applicable

Brugada Syndrome Substrate Characterization and Ablation

Brugada Syndrome
Maria Cecilia Hospital20 enrolled1 locationNCT05643209
Recruiting
Not Applicable

Comparative Effectiveness of Internet-based Versus Parent-Coached Cognitive-Behavioral Therapy For Children and Adolescents With Anxiety and OCD

Obsessive Compulsive Disorder (OCD)Panic DisorderGeneralized Anxiety Disorder (GAD)+6 more
Baylor College of Medicine174 enrolled1 locationNCT07024758